Sort by
Refine Your Search
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
part of this mission, UCL is launching a five-year, Medical Research Council-funded Deep Network Modelling in Neuro-oncology programme. This pioneering project aims to build a robust framework that
-
Research Career Development Fellowships in the Department of Cell and Developmental Biology, UCL: Expression of Interest for 2025 DEADLINE: The next deadline is 30th January 2026, 5 pm. The Research
-
About us UCL Biochemical Engineering (UCL-BE) is a world leader in bioprocessing, where researchers harness cutting-edge facilities and industry partnerships to transform breakthroughs in biology
-
health and disease. Prof Rick Adams is a leader in the field of Computational Psychiatry – the application of computational methods to psychiatric neuroscience. UCL is a world-leader in the fusion